AI Article Synopsis

  • * The study presents four cases (two CMML and two MDS) where severe itching occurred, with some symptoms showing up months before the cancer diagnosis.
  • * Chemotherapy and immunosuppressive treatments have mixed results on alleviating the itch, indicating that recognizing this symptom could help in the earlier diagnosis of these blood disorders.

Article Abstract

Intractable pruritus without visible primary skin lesions and refractory to antihistamines as a primary presentation of chronic myelomonocytic leukaemia (CMML) and myelodysplastic syndrome (MDS) is not well recognised. We present two cases of CMML and two cases of MDS with this challenging symptom. In two of them, the pruritus preceded the diagnosis of MDS/CMML by months. Various chemotherapeutic and immunosuppressive options were used with variable success. In one of the cases, the pruritus persisted despite achieving morphological remission of CMML with azacitidine but had a remarkable complete response to cladribine. The pathogenesis of intractable itching in CMML and MDS remains unclear but seems to be linked to the biology of these diseases and could precede definitive diagnostic features. Earlier diagnosis of these myeloid disorders may therefore be aided by increasing awareness among clinicians of the association with pruritus.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827816PMC
http://dx.doi.org/10.1136/bcr-2019-232480DOI Listing

Publication Analysis

Top Keywords

intractable pruritus
8
chronic myelomonocytic
8
myelomonocytic leukaemia
8
pruritus chronic
4
leukaemia myelodysplastic
4
myelodysplastic syndromes
4
syndromes case
4
case series
4
series intractable
4
pruritus
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!